Sunday, July 25, 2021 8:49:31 AM
Stock Symbol = $RAFA] Rafarma Pharmaceuticals, Inc. to build a pharmaceutical company within the Tashkent Pharma Park
Today, July 24 2021, a Trilateral Investment Agreement was signed in the amount of US $85 Million.
The signing ceremony of this document was attended by the director of the Uzbekistan Agency for the Development of the Pharmaceutical Industry, Mr. Sardor Kariev. Attending from the Tashkent Pharma Park Director, Mr. Sanzhar Babadzhanov and from Rafarma Pharmaceuticals - the Chairman of the Board of Directors of the American Company Mr. Ilya Shpurov.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM